Bacteremia Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: B29FBE002DDDEN
Market Monitor Global

Abstracts

Bacteremia (also bacteremia) is the presence of bacteria in the blood. Blood is normally a sterile environment, so the detection of bacteria in the blood (most commonly accomplished by blood cultures) is always abnormal. It is distinct from sepsis, which is the host response to the bacteria. Bacteremia can have several important health consequences. The immune response to the bacteria can cause sepsis and septic shock, which has a high mortality rate. Bacteria can also spread via the blood to other parts of the body (which is called hematogenous spread), causing infections away from the original site of infection, such as endocarditis or osteomyelitis. Treatment for bacteremia is with antibiotics, and prevention with antibiotic prophylaxis can be given in high-risk situations.

This report contains market size and forecasts of Bacteremia in Global, including the following market information:

Global Bacteremia Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Bacteremia market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bacteremia include Merck, Ronak Daru, Pfizer, Baxter, Theravance Biopharma, Novartis, Fresenius, Mylan and Sun Pharmaceutical Industries and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bacteremia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bacteremia Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Bacteremia Market Segment Percentages, by Type, 2021 (%)

• Antibiotics
• Vasopressors

Global Bacteremia Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Bacteremia Market Segment Percentages, by Application, 2021 (%)

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Bacteremia Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Bacteremia Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bacteremia revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Bacteremia revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Ronak Daru
• Pfizer
• Baxter
• Theravance Biopharma
• Novartis
• Fresenius
• Mylan
• Sun Pharmaceutical Industries
• Baxter

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bacteremia Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bacteremia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BACTEREMIA OVERALL MARKET SIZE

2.1 Global Bacteremia Market Size: 2021 VS 2028
2.2 Global Bacteremia Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bacteremia Players in Global Market
3.2 Top Global Bacteremia Companies Ranked by Revenue
3.3 Global Bacteremia Revenue by Companies
3.4 Top 3 and Top 5 Bacteremia Companies in Global Market, by Revenue in 2021
3.5 Global Companies Bacteremia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bacteremia Players in Global Market
  3.6.1 List of Global Tier 1 Bacteremia Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bacteremia Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Bacteremia Market Size Markets, 2021 & 2028
  4.1.2 Antibiotics
  4.1.3 Vasopressors
4.2 By Type - Global Bacteremia Revenue & Forecasts
  4.2.1 By Type - Global Bacteremia Revenue, 2017-2022
  4.2.2 By Type - Global Bacteremia Revenue, 2023-2028
  4.2.3 By Type - Global Bacteremia Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bacteremia Market Size, 2021 & 2028
  5.1.2 Retail Pharmacies
  5.1.3 Hospital Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Bacteremia Revenue & Forecasts
  5.2.1 By Application - Global Bacteremia Revenue, 2017-2022
  5.2.2 By Application - Global Bacteremia Revenue, 2023-2028
  5.2.3 By Application - Global Bacteremia Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bacteremia Market Size, 2021 & 2028
6.2 By Region - Global Bacteremia Revenue & Forecasts
  6.2.1 By Region - Global Bacteremia Revenue, 2017-2022
  6.2.2 By Region - Global Bacteremia Revenue, 2023-2028
  6.2.3 By Region - Global Bacteremia Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Bacteremia Revenue, 2017-2028
  6.3.2 US Bacteremia Market Size, 2017-2028
  6.3.3 Canada Bacteremia Market Size, 2017-2028
  6.3.4 Mexico Bacteremia Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Bacteremia Revenue, 2017-2028
  6.4.2 Germany Bacteremia Market Size, 2017-2028
  6.4.3 France Bacteremia Market Size, 2017-2028
  6.4.4 U.K. Bacteremia Market Size, 2017-2028
  6.4.5 Italy Bacteremia Market Size, 2017-2028
  6.4.6 Russia Bacteremia Market Size, 2017-2028
  6.4.7 Nordic Countries Bacteremia Market Size, 2017-2028
  6.4.8 Benelux Bacteremia Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Bacteremia Revenue, 2017-2028
  6.5.2 China Bacteremia Market Size, 2017-2028
  6.5.3 Japan Bacteremia Market Size, 2017-2028
  6.5.4 South Korea Bacteremia Market Size, 2017-2028
  6.5.5 Southeast Asia Bacteremia Market Size, 2017-2028
  6.5.6 India Bacteremia Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Bacteremia Revenue, 2017-2028
  6.6.2 Brazil Bacteremia Market Size, 2017-2028
  6.6.3 Argentina Bacteremia Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bacteremia Revenue, 2017-2028
  6.7.2 Turkey Bacteremia Market Size, 2017-2028
  6.7.3 Israel Bacteremia Market Size, 2017-2028
  6.7.4 Saudi Arabia Bacteremia Market Size, 2017-2028
  6.7.5 UAE Bacteremia Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Bacteremia Major Product Offerings
  7.1.4 Merck Bacteremia Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Ronak Daru
  7.2.1 Ronak Daru Corporate Summary
  7.2.2 Ronak Daru Business Overview
  7.2.3 Ronak Daru Bacteremia Major Product Offerings
  7.2.4 Ronak Daru Bacteremia Revenue in Global Market (2017-2022)
  7.2.5 Ronak Daru Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Bacteremia Major Product Offerings
  7.3.4 Pfizer Bacteremia Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Baxter
  7.4.1 Baxter Corporate Summary
  7.4.2 Baxter Business Overview
  7.4.3 Baxter Bacteremia Major Product Offerings
  7.4.4 Baxter Bacteremia Revenue in Global Market (2017-2022)
  7.4.5 Baxter Key News
7.5 Theravance Biopharma
  7.5.1 Theravance Biopharma Corporate Summary
  7.5.2 Theravance Biopharma Business Overview
  7.5.3 Theravance Biopharma Bacteremia Major Product Offerings
  7.5.4 Theravance Biopharma Bacteremia Revenue in Global Market (2017-2022)
  7.5.5 Theravance Biopharma Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Bacteremia Major Product Offerings
  7.6.4 Novartis Bacteremia Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Fresenius
  7.7.1 Fresenius Corporate Summary
  7.7.2 Fresenius Business Overview
  7.7.3 Fresenius Bacteremia Major Product Offerings
  7.7.4 Fresenius Bacteremia Revenue in Global Market (2017-2022)
  7.7.5 Fresenius Key News
7.8 Mylan
  7.8.1 Mylan Corporate Summary
  7.8.2 Mylan Business Overview
  7.8.3 Mylan Bacteremia Major Product Offerings
  7.8.4 Mylan Bacteremia Revenue in Global Market (2017-2022)
  7.8.5 Mylan Key News
7.9 Sun Pharmaceutical Industries
  7.9.1 Sun Pharmaceutical Industries Corporate Summary
  7.9.2 Sun Pharmaceutical Industries Business Overview
  7.9.3 Sun Pharmaceutical Industries Bacteremia Major Product Offerings
  7.9.4 Sun Pharmaceutical Industries Bacteremia Revenue in Global Market (2017-2022)
  7.9.5 Sun Pharmaceutical Industries Key News
7.10 Baxter
  7.10.1 Baxter Corporate Summary
  7.10.2 Baxter Business Overview
  7.10.3 Baxter Bacteremia Major Product Offerings
  7.10.4 Baxter Bacteremia Revenue in Global Market (2017-2022)
  7.10.5 Baxter Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bacteremia Market Opportunities & Trends in Global Market
Table 2. Bacteremia Market Drivers in Global Market
Table 3. Bacteremia Market Restraints in Global Market
Table 4. Key Players of Bacteremia in Global Market
Table 5. Top Bacteremia Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Bacteremia Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Bacteremia Revenue Share by Companies, 2017-2022
Table 8. Global Companies Bacteremia Product Type
Table 9. List of Global Tier 1 Bacteremia Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bacteremia Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bacteremia Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Bacteremia Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Bacteremia Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Bacteremia Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Bacteremia Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Bacteremia Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Bacteremia Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Bacteremia Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Bacteremia Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Bacteremia Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Bacteremia Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Bacteremia Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Bacteremia Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Bacteremia Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Bacteremia Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Bacteremia Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Bacteremia Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Bacteremia Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Bacteremia Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Bacteremia Product Offerings
Table 32. Merck Bacteremia Revenue (US$, Mn), (2017-2022)
Table 33. Ronak Daru Corporate Summary
Table 34. Ronak Daru Bacteremia Product Offerings
Table 35. Ronak Daru Bacteremia Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Bacteremia Product Offerings
Table 38. Pfizer Bacteremia Revenue (US$, Mn), (2017-2022)
Table 39. Baxter Corporate Summary
Table 40. Baxter Bacteremia Product Offerings
Table 41. Baxter Bacteremia Revenue (US$, Mn), (2017-2022)
Table 42. Theravance Biopharma Corporate Summary
Table 43. Theravance Biopharma Bacteremia Product Offerings
Table 44. Theravance Biopharma Bacteremia Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Bacteremia Product Offerings
Table 47. Novartis Bacteremia Revenue (US$, Mn), (2017-2022)
Table 48. Fresenius Corporate Summary
Table 49. Fresenius Bacteremia Product Offerings
Table 50. Fresenius Bacteremia Revenue (US$, Mn), (2017-2022)
Table 51. Mylan Corporate Summary
Table 52. Mylan Bacteremia Product Offerings
Table 53. Mylan Bacteremia Revenue (US$, Mn), (2017-2022)
Table 54. Sun Pharmaceutical Industries Corporate Summary
Table 55. Sun Pharmaceutical Industries Bacteremia Product Offerings
Table 56. Sun Pharmaceutical Industries Bacteremia Revenue (US$, Mn), (2017-2022)
Table 57. Baxter Corporate Summary
Table 58. Baxter Bacteremia Product Offerings
Table 59. Baxter Bacteremia Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Bacteremia Segment by Type in 2021
Figure 2. Bacteremia Segment by Application in 2021
Figure 3. Global Bacteremia Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bacteremia Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bacteremia Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bacteremia Revenue in 2021
Figure 8. By Type - Global Bacteremia Revenue Market Share, 2017-2028
Figure 9. By Application - Global Bacteremia Revenue Market Share, 2017-2028
Figure 10. By Region - Global Bacteremia Revenue Market Share, 2017-2028
Figure 11. By Country - North America Bacteremia Revenue Market Share, 2017-2028
Figure 12. US Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Bacteremia Revenue Market Share, 2017-2028
Figure 16. Germany Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 17. France Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Bacteremia Revenue Market Share, 2017-2028
Figure 24. China Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 28. India Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Bacteremia Revenue Market Share, 2017-2028
Figure 30. Brazil Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Bacteremia Revenue Market Share, 2017-2028
Figure 33. Turkey Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Bacteremia Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Bacteremia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Ronak Daru Bacteremia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Bacteremia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Baxter Bacteremia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Theravance Biopharma Bacteremia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Bacteremia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Fresenius Bacteremia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Mylan Bacteremia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sun Pharmaceutical Industries Bacteremia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Baxter Bacteremia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)